HomeNANEXA • STO
add
Nanexa AB
Previous close
kr 2.01
Day range
kr 1.93 - kr 2.08
Year range
kr 0.70 - kr 3.15
Market cap
312.59M SEK
Avg Volume
269.72K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Investing.com
1 hour ago
Nasdaq grants HCW Biologics extension to regain compliance with listing rules
0.078%
3.23%
Financials
Income Statement
Revenue
Net income
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 8.83M | -17.73% |
Operating expense | 9.59M | -26.89% |
Net income | -5.90M | 1.88% |
Net profit margin | -66.78 | -19.27% |
Earnings per share | — | — |
EBITDA | -2.13M | 40.49% |
Effective tax rate | 0.46% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 40.26M | -2.54% |
Total assets | 126.55M | 10.58% |
Total liabilities | 36.63M | 33.44% |
Total equity | 89.92M | — |
Shares outstanding | 156.91M | — |
Price to book | 3.53 | — |
Return on assets | -10.12% | — |
Return on capital | -11.50% | — |
Cash Flow
Net change in cash
| (SEK) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.90M | 1.88% |
Cash from operations | -2.99M | -717.21% |
Cash from investing | -7.20M | -28.35% |
Cash from financing | 1.24M | 325.05% |
Net change in cash | -8.95M | -37.15% |
Free cash flow | -8.15M | -79.97% |
About
Founded
2007
Website
Employees
15
